About
Sundar Kodiyalam is a managing director of Vatera Holdings and a co-founder of Vatera Healthcare Partners. In addition to being a member of the Board of Directors of Melinta Therapeutics, he is a member of the Boards of Directors of Ekteino Laboratories Inc., ImmusanT, Inc., and Edgemont Pharmaceuticals LLC. Mr. Kodiyalam also previously served on the Board of Directors of Pearl Therapeutics until its sale to AstraZeneca. Prior to Vatera, Mr. Kodiyalam worked as senior vice president, corporate development and new business opportunities at Kos Pharmaceuticals. During his four-year tenure at Kos, sales contributions from licensed products grew from 0% to more than 25% as a result of transactions completed by Mr. Kodiyalam and his team. The company also boasted a robust late-stage pipeline partially built through successful licensing efforts. Mr. Kodiyalam was also a key member of the management team that worked on the sale of Kos Pharmaceuticals to Abbott Laboratories. Prior to Kos, M
Position in the VCSift Database
- • 5 investors at Vatera Healthcare Partners are tracked.
- • 160 investors hold the Founder & Managing Director role in VCSift. Sundar Kodiyalam is one of them.
- • 18 investors are based in Edison, New Jersey, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Edison, US
Contact Information
Find more investors like Sundar
Search Investors